Histone deacetylases and cancer: Causes and therapies

被引：1594
|
作者：
Marks, PA
Rifkind, RA
Richon, VM
Breslow, R
Miller, T
Kelly, WK
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Columbia Univ, New York, NY 10027 USA
来源：
NATURE REVIEWS CANCER | 2001年 / 1卷 / 03期
关键词：
D O I：
10.1038/35106079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Together, histone acetyltransferases and histone deacetylases (HDACs) determine the acetylation status of histones. This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumours cells by altering the transcription of a small number of genes. HDAC inhibitors are proving to be an exciting therapeutic approach to cancer, but how do they exert this effect?.
引用
收藏
页码：194 / 202
页数：9
相关论文
共 50 条
  • [41] Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
    Mottet, D.
    Castronovo, V.
    [J]. CURRENT CANCER DRUG TARGETS, 2010, 10 (08) : 898 - 913
  • [42] Histone deacetylases function as novel potential therapeutic targets for cancer
    Zhang, Hui
    Shang, Yu-Ping
    Chen, Hong-ying
    Li, Jun
    [J]. HEPATOLOGY RESEARCH, 2017, 47 (02) : 149 - 159
  • [43] Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer
    Stazi, Giulia
    Fioravanti, Rossella
    Mai, Antonello
    Mattevi, Andrea
    Valente, Sergio
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 50 : 89 - 100
  • [44] Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    Xiang, Xue-Song
    Li, Peng-Cheng
    Wang, Wen-Quan
    Liu, Liang
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (01):
  • [45] Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
    Dimitrios Schizas
    Aikaterini Mastoraki
    Leon Naar
    Eleftherios Spartalis
    Diamantis I Tsilimigras
    Georgia-Sofia Karachaliou
    George Bagias
    Dimitrios Moris
    [J]. World Journal of Gastroenterology, 2018, 24 (41) : 4635 - 4642
  • [46] Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
    Falkenberg, Katrina J.
    Johnstone, Ricky W.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) : 673 - 691
  • [47] Histone deacetylases as therapeutic targets - From cancer to cardiac disease
    Abend, Alon
    Kehat, Izhak
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 147 : 55 - 62
  • [48] Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
    Elena Ceccacci
    Saverio Minucci
    [J]. British Journal of Cancer, 2016, 114 : 605 - 611
  • [49] Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer
    Benard, Anne
    Goossens-Beumer, Ines J.
    van Hoesel, Anneke Q.
    Horati, Hamed
    de Graaf, Wouter
    Putter, Hein
    Zeestraten, Eliane C. M.
    Liefers, Gerrit-Jan
    van de Velde, Cornelis J. H.
    Kuppen, Peter J. K.
    [J]. HISTOPATHOLOGY, 2015, 66 (02) : 270 - 282
  • [50] Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
    Wynne Sim
    Wei-Meng Lim
    Ling-Wei Hii
    Chee-Onn Leong
    Chun-Wai Mai
    [J]. World Journal of Gastroenterology, 2022, 28 (18) : 1934 - 1945
12345